NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Drug Compounding -- standards Remove constraint Subjects: Drug Compounding -- standards

Search Results

3. Questionable billing for compounded topical drugs in Medicare Part D

5. Compliance policy for certain compounding of oral oxitriptan (5-HTP) drug products for patients with tetrahydrobiopterin (BH4) deficiency: immediately in effect guidance for industry

6. Liposome drug products: chemistry, manufacturing, and controls : human pharmacokinetics and bioavailability : and labeling documentation

7. E11(R1) addendum: clinical investigation of medicinal products in the pediatric population

9. Most hospitals obtain compounded drugs from outsourcing facilities, which must meet FDA quality standards

10. Temporary policy for preparation of certain alcohol-based hand sanitizer products during the public health emergency (COVID-19)